The present invention relates to a pharmaceutical composition for preventing or treating coronavirus infection-19 (COVID-19), specifically, a carbocyclic nucleoside derivative represented by Formula A-1 or Formula A-2 Or it relates to a pharmaceutical composition comprising a pharmaceutically acceptable salt thereof.
展开▼